Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $175.44 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $99.64 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $55.85 | 3 | $0 (2021) |
| Philips North America LLC | $19.95 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.95 | 1 | Philips North America LLC ($19.95) |
| 2023 | $99.64 | 1 | ABIOMED ($99.64) |
| 2021 | $26.85 | 2 | GlaxoSmithKline, LLC. ($26.85) |
| 2020 | $29.00 | 1 | GlaxoSmithKline, LLC. ($29.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | Philips North America LLC | (6585) Omniwire (Device) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: Medical Device | ||||||
| 08/16/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $99.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 749 | 844 | $330,723 | $58,981 |
| 2022 | 10 | 859 | 1,097 | $468,797 | $91,512 |
| 2021 | 11 | 744 | 1,023 | $533,991 | $107,503 |
| 2020 | 14 | 735 | 1,065 | $575,958 | $117,069 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 193 | 249 | $133,953 | $23,804 | 17.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $65,758 | $10,926 | 16.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 65 | $57,265 | $10,585 | 18.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $13,695 | $2,610 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $13,576 | $2,588 | 19.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $13,609 | $2,461 | 18.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 19 | $8,066 | $1,816 | 22.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 102 | 102 | $4,998 | $973.08 | 19.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 41 | 41 | $6,390 | $912.25 | 14.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 105 | 105 | $3,794 | $743.40 | 19.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 88 | 88 | $4,664 | $718.08 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $4,241 | $706.01 | 16.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 21 | 21 | $714.00 | $137.13 | 19.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 119 | 285 | $246,129 | $49,895 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 204 | $108,648 | $20,255 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $41,876 | $7,477 | 17.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 54 | 76 | $31,121 | $6,316 | 20.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 30 | $16,134 | $3,283 | 20.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 136 | 137 | $6,602 | $1,276 | 19.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 127 | 128 | $6,784 | $1,017 | 15.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 140 | 141 | $5,076 | $974.54 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $5,625 | $865.05 | 15.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 23 | 23 | $802.00 | $153.99 | 19.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 151 | 368 | $327,478 | $66,149 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 170 | $80,350 | $16,912 | 21.0% |
About Dr. Patrick Weyer, MD
Dr. Patrick Weyer, MD is a Critical Care Medicine healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528041324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Weyer, MD has received a total of $175.44 in payments from pharmaceutical and medical device companies, with $19.95 received in 2024. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($175.44).
As a Medicare-enrolled provider, Weyer has provided services to 3,087 Medicare beneficiaries, totaling 4,029 services with total Medicare billing of $375,065. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Pawtucket, RI
- Active Since 11/25/2005
- Last Updated 07/23/2008
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1528041324
Products in Payments
- Impella (Device) $99.64
- TRELEGY ELLIPTA (Drug) $42.40
- (6585) Omniwire (Device) $19.95
- ANORO ELLIPTA (Drug) $13.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.